In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Quintiles

Executive Summary

Quintiles: Definitive agreement to acquire CerebroVascular Advances announced by Research Triangle Park, N.C.-based Quintiles May 8. Quintiles will issue 251,000 shares valued at approximately $14 mil. to fund the acquisition. The merger is expected to be completed later this year. Quintiles said that it expects to retain CVA CEO David Edwards and Chief Operating Officer Mike Dwyer. San Antonio-based CVA is a clinical research company specializing in stroke trials and had net income of $1.3 mil. on revenues of $4.5 mil. in 1996...
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS030188

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel